175 related articles for article (PubMed ID: 12496046)
1. Do thyroid disorders increase the risk of breast cancer?
Simon MS; Tang MT; Bernstein L; Norman SA; Weiss L; Burkman RT; Daling JR; Deapen D; Folger SG; Malone K; Marchbanks PA; McDonald JA; Strom BL; Wilson HG; Spirtas R
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1574-8. PubMed ID: 12496046
[TBL] [Abstract][Full Text] [Related]
2. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.
Gammon MD; Hibshoosh H; Terry MB; Bose S; Schoenberg JB; Brinton LA; Bernstein JL; Thompson WD
Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):413-9. PubMed ID: 10350436
[TBL] [Abstract][Full Text] [Related]
3. Risk of breast cancer associated with short-term use of oral contraceptives.
Folger SG; Marchbanks PA; McDonald JA; Bernstein L; Ursin G; Berlin JA; Daling JR; Norman SA; Strom BL; Weiss LK; Simon MS; Burkman RT; Malone KE; Spirtas R
Cancer Causes Control; 2007 Mar; 18(2):189-98. PubMed ID: 17216547
[TBL] [Abstract][Full Text] [Related]
4. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
[TBL] [Abstract][Full Text] [Related]
5. Anthropometry and the risk of epithelial ovarian cancer.
Greer JB; Modugno F; Ness RB; Allen GO
Cancer; 2006 May; 106(10):2247-57. PubMed ID: 16596653
[TBL] [Abstract][Full Text] [Related]
6. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
[TBL] [Abstract][Full Text] [Related]
7. Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma.
Cristofanilli M; Yamamura Y; Kau SW; Bevers T; Strom S; Patangan M; Hsu L; Krishnamurthy S; Theriault RL; Hortobagyi GN
Cancer; 2005 Mar; 103(6):1122-8. PubMed ID: 15712375
[TBL] [Abstract][Full Text] [Related]
8. Lifetime physical activity and the risk of breast cancer: a case-control study.
Kruk J
Cancer Detect Prev; 2007; 31(1):18-28. PubMed ID: 17296272
[TBL] [Abstract][Full Text] [Related]
9. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
10. Tonsillectomy and breast cancer risk in the Western New York Diet Study.
Brasky TM; Bonner MR; Dorn J; Marhsall JR; Vena JE; Brasure JR; Freudenheim JL
Cancer Causes Control; 2009 Apr; 20(3):369-74. PubMed ID: 18953693
[TBL] [Abstract][Full Text] [Related]
11. Cigarette smoking and risk of breast carcinoma in situ.
Trentham-Dietz A; Nichols HB; Egan KM; Titus-Ernstoff L; Hampton JM; Newcomb PA
Epidemiology; 2007 Sep; 18(5):629-38. PubMed ID: 17700252
[TBL] [Abstract][Full Text] [Related]
12. Ovarian cysts and breast cancer: results from the Women's Contraceptive and Reproductive Experiences Study.
Knight JA; Lesosky M; Blackmore KM; Voigt LF; Holt VL; Bernstein L; Marchbanks PA; Burkman RT; Daling JR; Whittemore AS
Breast Cancer Res Treat; 2008 May; 109(1):157-64. PubMed ID: 17616808
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina.
Bradbury BD; Lash TL; Kaye JA; Jick SS
Cancer; 2005 Mar; 103(6):1114-21. PubMed ID: 15712362
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Sluss P; Hankinson SE
J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279
[TBL] [Abstract][Full Text] [Related]
15. Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancer.
Strom BL; Berlin JA; Weber AL; Norman SA; Bernstein L; Burkman RT; Daling JR; Deapen D; Folger SG; Malone KE; Marchbanks PA; Simon MS; Ursin G; Weiss LK; Spirtas R
Contraception; 2004 May; 69(5):353-60. PubMed ID: 15105056
[TBL] [Abstract][Full Text] [Related]
16. Cadmium exposure and breast cancer risk.
McElroy JA; Shafer MM; Trentham-Dietz A; Hampton JM; Newcomb PA
J Natl Cancer Inst; 2006 Jun; 98(12):869-73. PubMed ID: 16788160
[TBL] [Abstract][Full Text] [Related]
17. Urinary melatonin levels and breast cancer risk.
Schernhammer ES; Hankinson SE
J Natl Cancer Inst; 2005 Jul; 97(14):1084-7. PubMed ID: 16030307
[TBL] [Abstract][Full Text] [Related]
18. Reproductive and menstrual history and papillary thyroid cancer risk: the San Francisco Bay Area thyroid cancer study.
Sakoda LC; Horn-Ross PL
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):51-7. PubMed ID: 11815401
[TBL] [Abstract][Full Text] [Related]
19. Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study.
Lee E; Ma H; McKean-Cowdin R; Van Den Berg D; Bernstein L; Henderson BE; Ursin G
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3170-8. PubMed ID: 18990759
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women.
Ren Z; Cai Q; Shu XO; Cai H; Li C; Yu H; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1290-5. PubMed ID: 15298948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
